Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 62

Tests names and labsConditionsGenes and analytesMethods

BRCA 1 and BRCA2 Gene Sequencing

GENETIX Centro de Investigación en Genética Humana y Reproductiva
Colombia
42
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
3625
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Breast ovarian cancer panel

Centogene AG - the Rare Disease Company
Germany
1914
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BRCA2-Hereditary Cancer of the Breast

Molecular Genetics Laboratory London Health Sciences Centre
Canada
51
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

BRCA2 Gene Sequencing

Michigan Medical Genetics Laboratories University of Michigan
United States
71
  • C Sequence analysis of the entire coding region

BRCA2 deletion/duplication testing

Michigan Medical Genetics Laboratories University of Michigan
United States
61
  • D Deletion/duplication analysis

BRCA1 full gene sequencing

Michigan Medical Genetics Laboratories University of Michigan
United States
71
  • C Sequence analysis of the entire coding region

BRCA1 deletion/duplication testing

Michigan Medical Genetics Laboratories University of Michigan
United States
71
  • D Deletion/duplication analysis

BRCA1 and BRCA2 mutation panel

Michigan Medical Genetics Laboratories University of Michigan
United States
82
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

breast cancer 1

Vanak Pathobiology Laboratory
Iran
41
  • X Mutation scanning of select exons

Hereditary breast/ovarian cancer - analysis the BRCA1 gene mutations in accordance with EMQN recommendations

Laboratory of Human Genetics Health Care Center GENOMED
Poland
61
  • C Sequence analysis of the entire coding region

Hereditary breast/ovarian cancer - analysis the BRCA2 gene mutations in accordance with EMQN recommendations

Laboratory of Human Genetics Health Care Center GENOMED
Poland
61
  • C Sequence analysis of the entire coding region

Li Fraumeni Syndrome

Molecular Genetics Laboratory London Health Sciences Centre
Canada
51
  • C Sequence analysis of the entire coding region

BRCA 1 and BRCA2 Gene Sequencing

Center for Comprehensive Genetic Services Shahid Beheshti University of Medical Sciences
Iran
42
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Prostate Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ovarian Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Endometrial Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Focus Panel

Fulgent Clinical Diagnostics Lab Fulgent Diagnostics
United States
5814
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 62

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.